Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 11 - 20 of 122 results for "Biotech"

Hearts & Minds revalues position amid Opthea fallout

JAMIE WILLIAMSON  |  WEDNESDAY, 26 MAR 2025
... January end. Both said they did so recognising the potential for a positive result from another upcoming clinical trial. The biotech firm is now exploring possible options in respect of its clinical trial program "with a view to identifying whether there ...

Regal slashes holdings in Opthea over insolvency concerns

KARREN VERGARA  |  TUESDAY, 25 MAR 2025
... announcement. It remains suspended on the ASX and Nasdaq until March 31. Opthea last traded at 60 cents per share. The biotech firm is now exploring possible options in respect of its clinical trial program "with a view to identifying whether there is ...

Binance Labs becomes a family office

KARREN VERGARA  |  TUESDAY, 28 JAN 2025
... crypto. With Ella's leadership, we aim to support visionary founders who are building the future in Web3, AI, and biotech." Last April 2024, CZ was sentenced to four months in prison after pleading guilty to violating US money laundering laws. He ...

Hostplus ups fees, makes $125m investment

ELIZA BAVIN  |  WEDNESDAY, 27 NOV 2024
... total commitment to $435 million, backing companies like green hydrogen pathfinder Hysata, chronic lung disease therapy biotech RAGE and sustainable lithium extractor Electralith. IP Group ANZ chief executive Michael Molinari said the increased investment ...

Major global trends impacting advisers

ELIZA BAVIN  |  FRIDAY, 25 OCT 2024
High interest rates (70%), economic downturn and inflation risks (both 68.8%), and the impact of central bank policy (61.3%) usurped any concerns about this year's election cycle for Australian financial advisers and investors, according to this year's ...

QIC invests in Australian biotech start-up

ELIZA BAVIN  |  MONDAY, 8 JUL 2024
Queensland Investment Corporation (QIC) has announced a new investment in a Brisbane-based biotech start-up. Gelomics has developed a 3D tissue culture system that allows scientists to grow microscopic representations of human tissue to eliminate the ...

QIC adds to streak of venture capital investments

ANDREW MCKEAN  |  WEDNESDAY, 5 JUN 2024
... (QIC) has agreed to become a cornerstone investor in early and growth-stage fund Sprint Ventures, while also investing in biotech venture capital firm Brandon Capital. Yesterday, Financial Standard reported that QIC's venture capital development fund ...

Perennial Partners takes over Australian Unity fund

ANDREW MCKEAN  |  WEDNESDAY, 8 MAY 2024
Perennial Partners has agreed with Australian Unity Funds Management Limited (AUFM) to take over the investment management of the latter's Future of Healthcare Fund. AUFM will also step down as trustee of the fund, with Perennial taking over as trustee. ...

Uniseed partners with major Aussie universities

CASSANDRA BALDINI  |  WEDNESDAY, 15 NOV 2023
Uniseed has joined forces with major Australian universities, doubling the number of research partners in the fund. Monash University has joined Uniseed as its full partner, along with the University of Newcastle, University of Technology Sydney, Western ...

Super funds embrace offshore investment, internal teams

ANDREW MCKEAN  |  WEDNESDAY, 28 JUN 2023
... Investing offshore also allows the fund to access investments that you can't easily access in Australia, whether it's biotech or other sectors," he said. Nevertheless, JPMorgan's report clarified that while large funds heavily invested in ...